XML 49 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 25, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Roll Forward
A summary of the status of the Company’s stock option plan as of December 25, 2022, and changes in options outstanding under the plan for the year ended December 25, 2022, is as follows:

Number of
Shares Under Option		Weighted-Average Exercise Price per ShareWeighted-
Average
Remaining
Contractual
Term
(in years)		Aggregate Intrinsic Value
(000’s)(000’s)
Options outstanding at December 26, 202142 $4.98 1.0$622.9 
Granted— $— 
Exercised(24)$4.98 
Forfeited or expired— $— 
Options outstanding at December 25, 202218 $4.98 0.0$79.9 
Options exercisable at December 25, 202218 $4.98 0.0$79.9 
Schedule of Grants and Exercises Under the Company's Option Plans
During the years ended December 25, 2022, December 26, 2021, and December 27, 2020, the following values relate to the exercises under the Company’s option plans:

202220212020
Total intrinsic value of options exercised (in thousands)$163.0 $— $1,446.4 
Schedule of Restricted Stock Units Activity
The following table summarizes the Company’s Restricted Stock Unit activity:

Restricted
Stock Units
(000’s)		Weighted-Average Grant Date Fair Value
Nonvested balance at December 26, 20214,878 $12.74 
Granted1,577 $18.85 
Vested(1,716)$17.75 
Forfeited or expired(80)$17.61 
Nonvested balance at December 25, 20224,659 $12.88 
Schedule of Assumptions and Resulting Fair Values of Options Granted The assumptions and resulting fair values of options granted for 2022, 2021 and 2020 were as follows:
Offering
Periods
January 1 to
December 31
2022		Offering
Periods
January 1 to
December 31
2021		Offering
Periods
January 1 to
December 31,
2020
Expected term (in years)(1)0.50.50.5
Risk-free interest rate(2)
0.19% - 2.51%
0.06% - 0.09%
0.18% - 1.60%
Expected volatility(3)
40.52% - 60.79%
41.40% - 45.93%
44.14% - 82.75%
Expected dividend yield(4)—%—%—%
Weighted average grant-date fair value per share$4.80$7.60$5.43

(1) The expected term is equivalent to the offering period.
(2) The risk-free interest rate is based on U.S. Treasury yields in effect at the time of grant with a term equal to the expected term.
(3) The Company estimated implied volatility based upon trailing volatility.
(4) The Company has no history or expectation of paying dividends on its common stock.